Home LiteratureArticle Details
PMID: 4193935 Published · ppublish English Journal Article

Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

The Journal of experimental medicine ·Vol. 131 ·No. 4 ·1970-04-01 ·Pages 643-57

Lachmann PJ, Thompson RA

Abstract

It has been shown that the "activated reactor" that is produced in certain human sera by complement activation is a stable complex of the fifth and sixth component of complement (C56). On interaction with C7, the indicator factor, a complex C567 is formed which for a short time (half-life less than 1 min) has an activated binding site and can attach itself to normal red cell membranes, conferring on them the hemolytic properties of the "heat stable" complement intermediate EC 1 approximately 7, the capacity to be lysed by C8 and C9. These cells have neither antibody nor the complement components up to C3 bound on them. The binding site-activated C567c-can similarly bind to other hydrophobic surfaces, including agarose gel where it forms a "stainable line". If the complex is not bound to a surface, the binding site decays and the resulting complex will no longer give rise to lysis. However it will still inactivate C8 and C9 in solution. The sera that can generate activated reactor apparently do so because they have an excess of C5 and C6, compared to their content of C7. The phenomenon of reactive lysis thus represents complement-mediated lysis of unsensitized cells initiated at the C5 stage by a stable complex (C56) which was generated by complement activation at a distance. The immunochemistry of the phenomenon is described and some of its implications discussed.

MeSH Terms
Animals Binding Sites Complement System Proteins/analysis,metabolism Hemolysis Humans Immunochemistry Immunodiffusion Molecular Weight Rabbits Zymosan gamma-Globulins/analysis
Chemicals
gamma-Globulins Complement System Proteins Zymosan
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lachmann P J
Thompson R A
References (10)
10 references, click to expand
  1. The gel-filtration behaviour of proteins related to their molecular weights over a wide range.
    Biochem J. 1965 Sep;96(3):595-606 PMID: 5862401
  2. A molecular concept of immune cytolysis.
    Arch Pathol. 1966 Sep;82(3):205-17 PMID: 5329367
  3. Further studies on the chemotactic factor of complement and its formation in vivo.
    Immunology. 1966 Aug;11(2):141-53 PMID: 4162237
  4. Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.
    Immunology. 1967 Jul;13(1):101-17 PMID: 4165629
  5. Complement: substitution of the terminal component in immune hemolysis by 1,10-phenanthroline.
    Science. 1967 Jul 28;157(3787):442-3 PMID: 4165677
  6. Reactive haemolysis--a distinctive form of red cell lysis.
    Immunology. 1968 May;14(5):745-62 PMID: 4172980
  7. Immunoconglutinins in human saliva--a group of unusual IgA antibodies.
    Immunology. 1970 Feb;18(2):157-69 PMID: 4984622
  8. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.
    J Exp Med. 1970 Apr 1;131(4):629-41 PMID: 4193934
  9. A theoretical and experimental analysis of double diffusion precipitin reactions in gels, and its application to characterization of antigens.
    Immunology. 1960 Jan;3:95-106 PMID: 13792817
  10. THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.
    J Clin Invest. 1965 Sep;44:1534-46 PMID: 14332166
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1970-04-01
Pages
643-57
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2138770
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com